Companies/US/IMRX

IMMUNEERING CORPORATION

Last · NASDAQ$3.42-0.14 (-3.93%)close · yahoo · 13h ago
Vol 803.7K ≈ 2.75M
Market cap$221.27M64.7M sh
P/E · TTM-3.7fwd -2.7 · eps -0.93 · loss
Beta0.46vs S&P 500
Div yield0.00%annual · TTM
52w range
$3.41$8.48
Volume803.7Ksession

Issuer

Legal nameIMMUNEERING CORPORATION
HQUnited States (US)
ListingUS IMRX
ISINUS45254E1073
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001790340
CIK0001790340
Websitewww.immuneering.com
LinkedIn
Employees55
AddressImmuneering Corp. 245 Main Street 02142, Cambridge
Loading chart…

Upcoming earnings

1 event
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.31
Est. revenue
0
View upcoming earnings →

Press & signals

3 recent
  • GlobeNewswire

    Immuneering Comments on Today’s FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients

  • GlobeNewswire

    Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates

  • GlobeNewswire

    Immuneering Corporation Announces Grants of Inducement Awards

Documents

FormReporting forFiledFlags
8-K8-K: Results of Operations and Financial Condition
2026-08-052026-08-050
10-Q
2026-06-302026-08-05 3
Showing 2 of 2 filings